Navigation Links
CoreLab Partners Launches Advanced Imaging Application

PRINCETON, N.J., Jan. 10, 2011 /PRNewswire/ -- CoreLab Partners, Inc, the global entity resulting from the merger between RadPharm, Inc and Medifacts International, has launched a new advanced imaging application named ImagEngine®.

"We are pleased to announce the release of our proprietary imaging sciences application which will further enhance the drug development continuum by offering sponsors advanced technologies and integrated data management processes, all designed to ensure the timely execution on project timelines," said CoreLab Partners' President and Chief Executive Officer, Dr. Mike Woehler. "Through substantial investment and our close strategic relationship with a global pioneer in the development of complex scientific technologies, we have created a state-of-the-art imaging sciences tool that will serve as a platform for a series of enabling applications. This will lead to continued expansion of our overall capabilities and imaging modalities, to include new therapeutic areas, over the next several months," added Woehler.  

The ImagEngine® system is a unique software program which will be utilized exclusively by CoreLab Partners' board-certified Radiologists to calibrate, read, annotate and review digitized medical images. This exciting advancement is an integral component of a technological suite of solutions to enhance productivity, improve quality and accelerate timelines.  

Various elements of the staged roll-outs will include:

  • The ability to load and display DICOM images, associated measurement and calibration objects
  • Segmentation tools
  • Registration tools to support multi-modality fusion with synchronized scrolling and lesion propagation
  • Registration of multi-modality voxel volumes
  • Calculates geometric and intensity based statistics
  • Object tagging with meta-data such as user ID, anatomical site code and label
  • Full integration with CoreLab Partners' information flow, repository and Oracle Clinical database
  • Support for centralized storage and retrieval of application configuration information based on project protocol.

About CoreLab Partners, Inc

CoreLab Partners, with offices in North America, Europe and Asia, provides comprehensive medical image assessment and cardiac safety services to the pharmaceutical, biotechnology and medical device industries. An efficient operational process facilitates successful new drug development programs by employing an experienced clinical operations team combined with full-time, board-certified, sub-specialty trained Radiologists, Cardiologists, nuclear medicine physicians and Oncologists. CoreLab Partners delivers disciplined solutions for the collection, analysis and management of patient images and cardiac safety & efficacy information during drug development. Driven by best-in-class science, emerging technologies and service quality, CoreLabs is a global leader providing imaging sciences in all major modalities complemented by service offerings in the conduct of ECG, Thorough QT, Holter Monitoring, Ambulatory Blood Pressure Monitoring, Spirometry, Glucometry and Pulse Wave Analysis.  


Kevin D. Duffy
Vice President, Global Business Development
Phone: 609-936-2600

This press release was issued through eReleases(R).  For more information, visit eReleases Press Release Distribution at

SOURCE CoreLab Partners, Inc
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
3. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
4. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
5. The Leukemia & Lymphoma Society and Cleveland Clinic Taussig Cancer Institute Announce Groundbreaking Partnership to Accelerate Drug Approvals
6. PDHI Launches ConXus Rewards, Announces Partnership With Hallmark Insights to Support Incentive-Driven Wellness Programs
7. UNICEF Partners With Causes on Facebook to Launch Charity Gift Feature
8. HealthMedias Strongest Single Quarter Results: Growth Driven by Product Enhancements, New Partnerships
9. iCAD Announces Partnership for Initiating Clinical Testing of Its Virtual Colonoscopy CAD Product
10. Catalyst Pharmaceutical Partners Begins Enrollment for Its U.S. Phase II Clinical Trial of CPP-109 in Patients with Cocaine Addiction
11. UM Maryland Industrial Partnerships Program Approves 18 Collaborative Research Projects, Worth $4.4 Million, Between University Faculty, State Technology Companies
Post Your Comments:
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
(Date:6/23/2016)... BOGOTA, Colombia , June 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a ... second affiliate in Latin America . ... ... ... ...
(Date:6/23/2016)... 23, 2016  Experian Health, the healthcare ... the patient payment and care experience, today ... products and services that will enhance the ... offerings. These award-winning solutions will enable healthcare ... compliant in an ever-changing environment and redefine ...
Breaking Medicine Technology:
(Date:6/26/2016)... Carolina (PRWEB) , ... June 26, 2016 , ... ... of a new product that was developed to enhance the health of felines. The ... centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, can ... Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey ... cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under ...
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
(Date:6/24/2016)... ... 24, 2016 , ... A recent article published June 14 on ... article goes on to state that individuals are now more comfortable seeking to undergo ... such as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... and Scientific Sessions in Dallas that it will receive two significant new grants ... grants came as PHA marked its 25th anniversary by recognizing patients, medical professionals ...
Breaking Medicine News(10 mins):